EC Healthcare expects to achieve a record-high sales volume in third quarter of FY22, Represents more than 40% Y-o-Y increase Jan 10, 2022 08:18 HKT/SGT Read More
Eisai Enters Into Exclusive Licensing Agreement with Roivant Concerning Investigational Anticancer Agent H3B-8800, a Splicing Modulator Jan 06, 2022 10:09 HKT/SGT Read More
B-cell lymphoma clinical trials now open on the TrialWire Platform Jan 05, 2022 17:10 HKT/SGT Read More
Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China) Jan 05, 2022 15:27 HKT/SGT Read More
Apollomics Inc. Announces CEO Guo-Liang Yu, PhD Appointed as Chairman of the Board for the BayHelix Group Jan 04, 2022 10:10 HKT/SGT Read More
Investigational Alzheimer's Disease Therapy Lecanemab Granted FDA Fast Track Designation Dec 24, 2021 08:26 HKT/SGT Read More